Our journey started in 2008

Ecclis has been founded in 2024. Although we are a young company, our dna goes back to 2008 when Jalmar Wesselink started the “Pharma Results” company. This company focussed mainly on Rx to OTC switches and provided services to major global pharmaceutical companies like Pfizer, Johnson & Johnson, Galderma, Sandoz, Spirig Pharma, Grünenthal and Boehringer Ingelheim.

Besides Rx to OTC switches, the activities were also extended to Brand & Business Development, Commercial Excellence Training. For retailers like Ahold, the company provided GDP (Good Distribution Practices) and RP (Responsible Person) in sourced services by secondment of Industrial Pharmacist to enable the distribution and sales of pharmaceutical products.

In 2021 Jalmar Wesselink suspended the “Pharma Results” activities to join the pharmaceutical company Boehringer Ingelheim GmbH in a Global role at their Headquarters in Germany, focussing on the sales of pharmaceuticals via online retailers like Amazon, Tmall and other international ecosystems.

In the summer of 2024 Jalmar Wesselink return to the Netherlands to continue the Pharma Results activities under the “Ecclis” umbrella. Pharma Results focusses on more opperational Pharmaceutical activities and business support, where the Ecclis organisation focusses on Strategic Consultancy and Commercial Excellence.

Ecclis is your growth partner in consumerized healthcare